The St Vincent’s Hospital Institutional Biosafety Committee (IBC) is responsible for the review, approval and ongoing monitoring of all research involving Genetically Modified Organisms (GMOs) conducted in OGTR-Accredited Organisations at St Vincent’s Hospital, Fitzroy Campus.
All dealings involving GMOs must receive approval from the St Vincent’s Hospital IBC before commencing.
Terms of Reference 2015
The four main classes of dealings involving GMOs are:
2016 IBC Meeting Dates / Agenda Closing Dates
The IBC reviews dealings conducted at the following OGTR-Accredited Organisations:
- St Vincent’s Hospital, Fitzroy Campus
- St Vincent’s Institute
- O’Brien Institute
- Bionics Institute
- University of Melbourne at St Vincent’s
- Centre for Eye Research Australia
For further information, please contact Melanie Asquith, IBC Secretary on 03 9288 3872 or email email@example.com